PapersPMID:26414973
Effect of Melatonin on Sleep in the Perioperative Period after Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- RCT
- Dose studied, every finding
- 6 mg oral melatonin about 60 minutes before bedtime, from 3 nights preoperatively until at least one week postoperatively
- Population, every finding
- Women undergoing breast cancer surgery, melatonin versus placebo, entire 2-week postoperative period
What moved
How to read these marks →“Administration of 6 mg oral melatonin approximately 1 hour before bedtime resulted in significantly increased sleep efficiency and reduced wake after sleep onset for the entire 2-week postoperative period.”
- Increases sleep efficiency
very limited
- Decreases wake after sleep onset (WASO)
very limited
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients undergoing breast cancer surgery (perioperative period)
- Participants
- 48
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 4
- Declined
- this platform holds no node for the endpoint
melatonin